General Information
Revision date
2025-01-06
Product name
Moxifloxacin Ophthalmic Solution USP, 0.5%
Icons in SDS
Company Information
company name
Somerset Therapeutics
Section 2
SECTION 2: Hazards identification
Note This product is Non-Hazardous and is approved by the FDA. It is an aqueous solution and is not considered to constitute a Hazard. Health Moxifloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to moxifloxacin, to other quinolones, or to any of the components in this medication.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
